| Net income (loss) | 1.69M |
| Depreciation and amortization | 68.53M |
| Amortization of leasehold interests | -49K |
| Amortization of acquired leases to rental revenue | |
| Amortization of deferred costs | 2.19M |
| Amortization of discount and other fees | -2.07M |
| Payment of capitalized tenant leasing costs | |
| Straight-line rent adjustment | |
| Non-cash impairment charges | 0 |
| Net gain on sale of properties and lease terminations | |
| Net realized gain on loans | |
| Equity in net (income) loss of joint ventures | |
| Gain on extinguishment of debt | 0 |
| Amortization of stock compensation | 2.63M |
| Provision for loan losses | |
| Restricted cash | -938K |
| Tenant and other receivables | -1.42M |
| Accrued interest | -30K |
| Other assets | 11.86M |
| Accounts payable, accrued expenses and other liabilities | 1.04M |
| Deferred revenue | 3.99M |
| Net cash provided by operating activities | 66M |
| Capital expenditures and leasehold costs | -2.36M |
| Deferred investment costs | |
| Proceeds from sale of real estate | 68.78M |
| Proceeds from sale of securities available for sale | |
| New investment originations and funded commitments | |
| Principal collections on investments | |
| Proceeds from loan syndications | |
| Investment in commercial mortgage-backed securities | |
| Distribution received from joint venture | 0 |
| Investment in joint venture | |
| Change in accrued interest income | |
| Purchase of marketable investments | |
| Sale of marketable investments | |
| Change in restricted cash from investing activities | |
| Net cash provided by (used in) investing activities | -830.88M |
| Repayment of unsecured credit facility | |
| Repayment of mortgage notes | |
| Purchase of interest rate caps | |
| Repayments of collateralized debt obligations | |
| Repurchase of collateralized debt obligations | |
| Payment for exchange of junior subordinated notes | |
| Deferred financing costs and other liabilities | -12.12M |
| Change in restricted cash from financing activities | -37K |
| Net cash used in financing activities | 602.91M |
| Net decrease in cash and cash equivalents | -161.96M |
| Cash and cash equivalents at beginning of period | 200.07M |
| Cash and cash equivalents at end of period | 38.11M |
| Deferred gain and other non-cash activity related to derivatives | |
| Interest paid | 22.39M |
| Income taxes paid | 1.24M |